These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3811645

  • 1. [Desferal treatment of aluminum poisoning; effect on serum concentrations of aluminum (Al), iron (Fe) and copper (Cu)].
    Günther K, Winnefeld K, Stein G, Sperschneider H, Schröter H, Fünfstück R.
    Z Urol Nephrol; 1986 Oct; 79(10):569-76. PubMed ID: 3811645
    [Abstract] [Full Text] [Related]

  • 2. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U.
    Schweiz Rundsch Med Prax; 1994 Jun 14; 83(24):738-56. PubMed ID: 8023059
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
    McCarthy JT, Milliner DS, Johnson WJ.
    Q J Med; 1990 Mar 14; 74(275):257-76. PubMed ID: 2117295
    [Abstract] [Full Text] [Related]

  • 4. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M, Popławski A, Kaliszewski Z, Juzwiuk J.
    Pol Merkur Lekarski; 1996 Oct 14; 1(4):232-4. PubMed ID: 9156931
    [Abstract] [Full Text] [Related]

  • 5. [Accumulation of aluminum in the dialyzed patient: incidence, causes and possibilities of prevention].
    Sulková S, Laurincová Z, Lapcík O, Dlhopolcek P, Stodolová E, Komonová D.
    Cas Lek Cesk; 1989 Jan 02; 128(1):16-9. PubMed ID: 2713883
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Aluminum osteopathy--experience with therapy].
    Sulková S.
    Vnitr Lek; 1993 May 02; 39(5):459-63. PubMed ID: 8351877
    [Abstract] [Full Text] [Related]

  • 8. Removal of trace metals by continuous ambulatory peritoneal dialysis after desferrioxamine B chelation therapy.
    Navarro JA, Granadillo VA, Rodríguez-Iturbe B, García R, Salgado O, Romero RA.
    Clin Nephrol; 1991 May 02; 35(5):213-7. PubMed ID: 1855329
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
    Abreo K, Brown ST, Sella M, Trapp G.
    J Lab Clin Med; 1989 Jan 02; 113(1):50-7. PubMed ID: 2909650
    [Abstract] [Full Text] [Related]

  • 12. Aluminum and deferoxamine kinetics in CAPD.
    Mactier RA.
    Adv Perit Dial; 1991 Jan 02; 7():26-9. PubMed ID: 1680440
    [Abstract] [Full Text] [Related]

  • 13. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF, D'Haese PC, Lamberts LV, Djukanovic L, Pejanovic S, Goodman WG, De Broe ME.
    Clin Nephrol; 1998 Aug 02; 50(2):69-76. PubMed ID: 9725776
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy and safety of long-term and low-dose desferrioxamine therapy against hyperaluminemia and the clinical symptoms associated with hyperaluminemia in patients undergoing maintenance hemodialysis].
    Kuramochi G.
    Nihon Jinzo Gakkai Shi; 1989 Mar 02; 31(3):267-73. PubMed ID: 2739124
    [Abstract] [Full Text] [Related]

  • 15. Predictive value of serum aluminium levels for bone accumulation in haemodialyzed patients.
    Costantini S, Giordano R, Vernillo I, Piccioni A, Zapponi GA.
    Ann Ist Super Sanita; 1989 Mar 02; 25(3):457-61. PubMed ID: 2624356
    [Abstract] [Full Text] [Related]

  • 16. Desferrioxamine in the treatment of aluminum overload.
    Ackrill P, Day JP.
    Clin Nephrol; 1985 Mar 02; 24 Suppl 1():S94-7. PubMed ID: 3842106
    [Abstract] [Full Text] [Related]

  • 17. Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication.
    Short AI, Winney RJ, Robson JS.
    Proc Eur Dial Transplant Assoc; 1980 Mar 02; 17():226-33. PubMed ID: 7243773
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
    Tielemans C, Collart F, Wens R, Smeyers-Verbeeke J, van Hooff I, Dratwa M, Verbeelen D.
    Clin Nephrol; 1985 Nov 02; 24(5):237-41. PubMed ID: 4075595
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.